Precise subcellular organelle-targeted analyses of the hepatotoxicity of rhubarb
Jianzhi Wu, Zhi Ma, Yinhao Zhang, Shuni Duan, Rong Sun, Runping Liu, Yijie Li, Xiaojiaoyang Li
Precise subcellular organelle-targeted analyses of the hepatotoxicity of rhubarb
Objective: Drug-induced liver injury (DILI) is the leading cause of acute liver failure and poses a significant challenge to human health. Rhubarb (Rheum officinale Baill. DaHuang) has been clinically used for its heat-clearing and diuresis-promoting effects. However, its toxic effects on different organelles in the liver require further validation.
Methods: We analyzed the potential targets affecting hepatotoxicity in rhubarb and the potential damage relationship with five major organelles, including microsomes, mitochondria, endoplasmic reticulum (ER), Golgi apparatus (GA), and lysosomes through Integrated Traditional Chinese Medicine (ITCM)/HERB databases and network pharmacology. We isolated and purified different organelles, incubated them with different fractions and monomers of rhubarb in an adenosine triphosphate (ATP) culture system and examined the structural and functional changes in the organelles using particle size analysis and molecular biological experiments to investigate whether rhubarb affects the damage and rupture of major organelles in the liver.
Results: By combining virtual predictions and experimental verification, our research confirmed that emodin isolated from the anthraquinone of rhubarb, catechin in the tannins of rhubarb, and palmitic acid in the organic acids of rhubarb caused the most significant functional and structural damage to the representative organelles. Among all the monomeric compounds, emodin caused the most damage to the microsome, mitochondria, ER, and lysosome; catechin induced microsome and GA damage; and palmitic acid caused the most damage to microsomes and GA in the liver, suggesting that rhubarb components may exert hepatotoxicity through multi-organelle injury.
Conclusions: Our findings revealed that rhubarb has varying degrees of damaging effects on different organelles, which in turn affects cellular life activities by impairing organelle morphology and function. This study provides a theoretical basis and technical support for a refined analysis of the toxic components and targets of rhubarb.
DILI / Emodin / Organelle toxicology / Palmitic acid / Rhubarb
[[1]] |
Cui Y, Chen LJ, Huang T, et al. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin. Chin J Nat Med 2020;18(6):425-435.
|
[[2]] |
Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med 2015;139(7):876-887.
|
[[3]] |
Björnsson H, Björnsson E. Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med 2022;97:26-31.
|
[[4]] |
Shinozawa T, Kimura M, Cai YQ, et al. High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology 2021;160(3): 831-846.e10.
|
[[5]] |
Swift B, Pfeifer ND, Brouwer KLR. Sandwich-cultured hepatocytes: an model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 2010;42(3):446-471.
|
[[6]] |
Kaur I, Vasudevan A, Rawal P, et al. Primary hepatocyte isolation and cultures: technical aspects, challenges and advancements. Bioengineering (Basel) 2023;10(2):131.
|
[[7]] |
Harrison SP, Baumgarten SF, Verma R, et al. Liver organoids: recent developments, limitations and potential. Front Med (Lausanne) 2021;8:574047.
|
[[8]] |
Vliegenthart ADB, Tucker CS, Del Pozo J, et al. Zebrafish as model organisms for studying drug-induced liver injury. Br J Clin Pharmacol 2014;78(6):1217-1227.
|
[[9]] |
Chen JQ, Li DW, Chen YY, et al. Elucidating dosage-effect relationship of different efficacy of rhubarb in constipation model rats by factor analysis. J Ethnopharmacol 2019;238:111868.
|
[[10]] |
Tolosa L, Gómez-Lechón MJ, Donato MT. High-content screening technology for studying drug-induced hepatotoxicity in cell models. Arch Toxicol 2015;89(7):1007-1022.
|
[[11]] |
Li SZ, Xia MH. Review of high-content screening applications in toxicology. Arch Toxicol 2019;93(12):3387-3396.
|
[[12]] |
Yang ZW, Zhang ZC, Zhao YZ, et al. Organelle interaction and drug discovery: towards correlative nanoscopy and molecular dynamics simulation. Front Pharmacol 2022;13:935898.
|
[[13]] |
Syed M, Skonberg C, Hansen SH. Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: possible role in drug induced liver injury (DILI). Toxicol In Vitro 2016;31:93-102.
|
[[14]] |
Cao YJ, Pu ZJ, Tang YP, et al. Advances in bio-active constituents, pharmacology and clinical applications of rhubarb. Chin Med 2017;12:36.
|
[[15]] |
Zhuang TX, Gu XY, Zhou NA, et al. Hepatoprotection and hepatotoxicity of Chinese herb Rhubarb (Dahuang): how to properly control the “General (Jiang Jun)” in Chinese medical herb. Biomed Pharmacother 2020;127:110224.
|
[[16]] |
Li SZ, Wang YM, Li CY, et al. Study on hepatotoxicity of rhubarb based on metabolomics and network pharmacology. Drug Des Devel Ther 2021;15:1883-1902.
|
[[17]] |
Jeon WY, Jin SE, Seo CS, et al. Safety assessment of water extract: study of acute and subacute toxicity, and influence on drug metabolizing enzymes. J Ethnopharmacol 2019;240:111913.
|
[[18]] |
Zhang F, Wu R, Liu YF, et al. Nephroprotective and nephrotoxic effects of Rhubarb and their molecular mechanisms. Biomed Pharmacother 2023;160:114297.
|
[[19]] |
Zhu SH, Jin J, Wang Y, et al. The endoplasmic reticulum stress response is involved in apoptosis induced by aloe-emodin in HK-2 cells. Food Chem Toxicol 2012;50(3-4):1149-1158.
|
[[20]] |
Wu JZ, Li YJ, Huang GR, et al. Mechanisms exploration of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma herb-pair for liver fibrosis prevention based on network pharmacology and experimental pharmacologylogy. Chin J Nat Med 2021;19(4):241-254.
|
[[21]] |
Lee HJ, Li CF, Ruan D, et al. Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion. Nat Commun 2019;10:2625.
|
[[22]] |
Joshi R, Paul M, Kumar A, et al. Role of calreticulin in biotic and abiotic stress signalling and tolerance mechanisms in plants. Gene 2019;714:144004.
|
[[23]] |
Harapas CR, Idiiatullina E, Al-Azab M, et al. Organellar homeostasis and innate immune sensing. Nat Rev Immunol 2022;22(9):535-549.
|
[[24]] |
Wang L, Liu JY, Miao ZJ, et al. Lipid droplets and their interactions with other organelles in liver diseases. Int J Biochem Cell Biol 2021;133:105937.
|
[[25]] |
Chandel NS. Mitochondria as signaling organelles. BMC Biol 2014;12:34.
|
[[26]] |
Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci 2016;73(1):79-94.
|
[[27]] |
Zhang SX, Wang JJ, Starr CR, et al. The endoplasmic reticulum: homeostasis and crosstalk in retinal health and disease. Prog Retin Eye Res 2024;98:101231.
|
[[28]] |
Kokubun H, Jin H, Aoe T. Pathogenic effects of impaired retrieval between the endoplasmic reticulum and Golgi complex. Int J Mol Sci 2019;20(22):5614.
|
[[29]] |
Chan YHM, Marshall WF. How cells know the size of their organelles. Science 2012;337(6099):1186-1189.
|
[[30]] |
Hu W, Zhong ZY, Ren XF, et al. The in vitro metabolism of GMDTC in liver microsomes of human, monkey, dog, rat and mouse: metabolic stability assessment, metabolite identification and interspecies comparison. J Pharm Biomed Anal 2023;236:115718.
|
[[31]] |
She RN, Liu DH, Liao J, et al. Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: from pathology to therapeutic potential. Front Cell Neurosci 2023;17:1191629.
|
[[32]] |
Frisbie CP, Lushnikov AY, Krasnoslobodtsev AV, et al. Post-ER stress biogenesis of Golgi is governed by giantin. Cells 2019;8(12):1631.
|
[[33]] |
Zhang YZ, Zhao QH, Duan HW, et al. Aflatoxin B1 exposure disrupts organelle distribution in mouse oocytes. PeerJ 2022;10:e13497.
|
[[34]] |
Mota M, Banini BA, Cazanave SC, et al. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism 2016;65(8):1049-1061.
|
[[35]] |
Yang D, Huang WY, Li YQ, et al. Acute and subchronic toxicity studies of rhein in immature andd-galactose-induced aged mice and its potential hepatotoxicity mechanisms. Drug Chem Toxicol 2022;45(3):1119-1130.
|
[[36]] |
Park YJ, Lee KH, Jeon MS, et al. Hepatoprotective potency of chrysophanol 8-glucoside from L. against hepatic fibrosis via regulation of the STAT3 signaling pathway. Int J Mol Sci 2020;21(23):9044.
|
[[37]] |
Sarhadynejad Z, Sharififar F, Pardakhty A, et al. Pharmacological safety evaluation of a traditional herbal medicine “Zereshk-e- Saghir” and assessment of its hepatoprotective effects on carbon tetrachloride induced hepatic damage in rats. J Ethnopharmacol 2016;190:387-395.
|
[[38]] |
Raal A, Pokk P, Arend A, et al. Trans-Resveratrol alone and hydroxystilbenes of (Rheum rhaponticum L.) root reduce liver damage induced by chronic ethanol administration: a comparative study in mice. Phytother Res 2009;23(4): 525-532.
|
[[39]] |
Shakya AK, Sharma N, Bhadauria M, et al. Ameliorative impact of herbal formulation -Majoon-Dabeed-ul-ward and Sharbate- Deenar against CCl4 induced liver toxicity via regulation of antioxidant enzymes and oxidative stress. Toxicol Res (Camb) 2022;11(5):819-830.
|
[[40]] |
Malik MS, Alsantali RI, Jassas RS, et al. Journey of anthraquinones as anticancer agents—a systematic review of recent literature. RSC Adv 2021;11(57):35806-35827.
|
[[41]] |
Zheng Q, Li S, Li XJY, et al. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. Chin Med 2021;16(1):102.
|
[[42]] |
Bove KE, Heubi JE, Balistreri WF, et al. Bile acid synthetic defects and liver disease: a comprehensive review. Pediatr Dev Pathol 2004;7(4):315-334.
|
/
〈 | 〉 |